News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Vinanet Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides a detailed overview of NRC Health (NRC) stock, including its current price, historical data, key financial metrics, and analyst ratings. It highlights the company's services in healthcare analytics and patient experience improvement, and compares its performance against the S&P 500. The โฆ
SCOTTSDALE, Ariz., Aug. 12, 2026 /PRNewswire/ -- Resideo Technologies (NYSE: REZI) ("Resideo"), a leading global developer and manufacturer of critical control and sensing solutions for residential end markets, today announced that Shane Harrison has been appointed as Resideo's Chief Financial Officer, effective September 1, โฆ
Long Cast Advisers, an independent investment adviser, highlighted NRC Health (NASDAQ: NRC) in its Q2 2026 investor letter, noting the company's strong performance, recent management changes, and a record backlog. Despite its positive outlook, the firm suggests that certain AI stocks may offer greater โฆ
Friday, August 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Space Exploration Technologies Corp. (SPCX), Arista Networks, Inc. (ANET) and The Boeing Co. (BA). These โฆ
Wall Street Zen upgraded National Research (NASDAQ:NRC) from "hold" to "buy", contributing to a consensus "Moderate Buy" rating and a $26.00 price target. The company recently exceeded quarterly earnings expectations, reporting $0.31 EPS against a projected loss of $0.15, with revenues slightly above estimates. โฆ
National Research Corp (NRC) has an institutional shareholding score of 5.00, placing it 95th out of 159 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 53.51%, marking a 9.20% increase quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 860.95K โฆ
This article assesses the risk profile of National Research Corp (NRC), highlighting its volatility, financial risk, and investment risk. With a current risk score of 5.22, NRC ranks 89th out of 159 in its industry, suggesting a moderate risk level. The company's beta of โฆ
National Research (NRC Health) reported Q2 results with an 11% year-over-year growth in total recurring contract value (TRCV) to $151.9 million. Revenue increased by approximately 4%, and adjusted EBITDA reached $9.4 million. The company highlighted strategic investments in customer success, product development, and its โฆ
This article provides a comprehensive stock analysis of National Research Corp (NRC) according to TradingKey's scoring system. It highlights NRC's stable fundamentals, high growth potential, and fair valuation within the Professional & Commercial Services industry. The analysis also notes high institutional ownership and a โฆ
Citizens Jmp has raised its price target for National Research (NASDAQ:NRC) from $23 to $26, maintaining a "market outperform" rating and suggesting a 22.27% potential upside. The company also recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue. National Research โฆ
National Research (NASDAQ:NRC) reached a new 52-week high after reporting better-than-expected quarterly earnings, with EPS of $0.31 surpassing estimates by $0.46 and revenue of $35.39 million also exceeding expectations. The company maintains a "Moderate Buy" consensus rating among analysts, with an average price target โฆ
This article provides a valuation analysis for National Research Corp (NRC), noting its current valuation score of 7.97, which ranks 114 out of 160 in the Professional & Commercial Services industry. The company's current P/E ratio is 53.13, falling below its recent high but โฆ
This article provides an overview of National Research Corp's (NRC) financial data, focusing on its revenue breakdown. It details the company's regional revenue contribution, showing that all reported revenue comes from the United States, but notes that full business segment data has not yet โฆ
This article provides a technical analysis of National Research Corp (NRC), highlighting its current price momentum score, support at $19.84, and resistance at $22.62. It details various technical indicators like MACD, RSI, and Moving Averages, offering buy, sell, or neutral signals for investment reference. โฆ
National Research Corp (NRC) currently holds a financial score of 7.50, placing it 66th out of 159 in the Professional & Commercial Services industry, indicating weak financial status but high operating efficiency. The company's latest quarterly revenue saw a 3.73% year-over-year increase, while net โฆ
National Research Corp (NRC) is trading at $21.290, with a market capitalization of $481.95M. Analysts have given the stock a "Buy" rating with a target price of $23.00, suggesting a 9.32% upside. The company is noted for stable fundamentals, high growth potential, and a โฆ
This article provides a detailed quarterly and annual income statement for National Research Corp (NRC), offering insights into its financial performance, including revenue, expenses, operating profit, and net income. It also includes frequently asked questions about how to interpret the income statement and key โฆ
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States